CRL
Charles River Laboratories
Health Care
Life Sciences Tools & Services
Wilmington, Massachusetts
Last filing: Feb 18, 2026 (FY2025)
Balance Sheet 14 Accounts • 5 Years
| Account | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| BS_Assets_Cash | $0 | — | — | $233.9M | — |
| BS_Assets_AcctsReceivable | $0 | — | — | $752.4M | — |
| BS_Assets_Inventory | $0 | — | — | $255.8M | — |
| BS_Assets_PrepaidExpenses | $0 | — | — | $107.6M | — |
| BS_Assets_PPE | $0 | — | — | $1.5B | — |
| BS_Assets_Goodwill | $0 | — | — | $2.8B | — |
| BS_Assets_IntangibleAssets | $0 | — | — | $955.3M | — |
| BS_Assets_OtherNoncurrent | $0 | — | — | $148.3M | — |
| BS_Liab_AccruedLiab | $0 | — | — | $219.8M | — |
| BS_Liab_OtherNoncurrent | $0 | — | — | $174.8M | — |
| BS_Equity_PreferredStock | $0 | — | — | $0 | — |
| BS_Equity_CommonStock | $0 | — | — | $509.0K | — |
| BS_Equity_TreasuryStock | $360.1M | — | — | $0 | — |
| BS_Equity_AOCI | $0 | — | — | $-262.1M | — |